4-((4-(Aminomethyl)benzyl)oxy)-6-chloropyrimidin-2-amine

Catalog No. :
ACSIPG580
CAS No. :
913817-45-5
Molecular Formula :
C12H13ClN4O
Molecular Weight :
264.72

IUPAC Name:4-((4-(aminomethyl)benzyl)oxy)-6-chloropyrimidin-2-amine

4-((4-(Aminomethyl)benzyl)oxy)-6-chloropyrimidin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$89.00Login to see priceIn stockIn stock
250mg95%$149.00Login to see priceIn stockIn stock
1g95%$408.00Login to see priceIn stockInquiry
5g95%$1428.00Login to see priceIn stockInquiry
25g95%$5878.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((4-(Aminomethyl)benzyl)oxy)-6-chloropyrimidin-2-amine
IUPAC Name4-((4-(aminomethyl)benzyl)oxy)-6-chloropyrimidin-2-amine
Molecular FormulaC12H13ClN4O
Molecular Weight264.72
SMILESNC1=NC(Cl)=CC(OCC2=CC=C(CN)C=C2)=N1
InChI KeyWFXBBTCFFCOXFA-UHFFFAOYSA-N
Synonym4-((4-(Aminomethyl)benzyl)oxy)-6-chloropyrimidin-2-amine;2-Pyrimidinamine, 4-[[4-(aminomethyl)phenyl]methoxy]-6-chloro-;SNAP-fusion protein ligand-1
CAS No.913817-45-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACSIPG580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSIPG580 route product structure diagram
    ACSIPG580913817-45-5 In Stock
Inquiry

2. ACSIPG580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACSIPG580 route product structure diagram
    ACSIPG580913817-45-5 In Stock
Inquiry

Comments (0)